MarketPeel
Insider Trading Intelligence
Pricing
…
TI

Thomas Insley

DRMA
CHIEF FINANCIAL OFFICER · DERMATA THERAPEUTICS, INC. · CIK 0001239545
FILING MIX · LIFETIME50%/50%
BUYS
1
SELLS
1
TOTAL VALUE
$0
COMPANIES
1
ACTIVE SINCE
Aug 2021
HOLDINGS NOW
0
AVG SELL PX
—
TRADE KIND
SHOWING 2 / 2
Trades · vs SPY
Loading price series…
Performance · forward returns vs SPY
No backtest data available for Thomas Insley. Backtests are computed for purchase (P) and sale (S) transactions with resolvable price history.
Holdings over time
DRMA · 0 shares · as of Aug 17, 2021
03,5847,16910,75314,337SHARES HELD
Trading cadence · quarterly flow
BUY ● SELL ●
2021
FLOW · 1 buys / 1 sellsCOVERAGE · 1 quarters
Form 4 filings · all activity
COMPANYTYPESHARESPRICEVALUEHELD AFTERTRADE DATEFILED
DRMA
DERMATA THERAPEUTICS, INC.
PURCHASE
Chief Financial Officer
4,581——14,337Aug 17, 2021Aug 17, 2021 ↗
DRMA
DERMATA THERAPEUTICS, INC.
SALE
Chief Financial Officer
30,910——0Aug 17, 2021Aug 17, 2021 ↗
Other insiders · DRMA
Loading peer insiders…
About this filer
CIK 0001239545
ROLE
Chief Financial Officer
PRIMARY
DRMA
COMPANIES
1
ACTIVE SINCE
Aug 2021
MARKETPEEL · /INSIDER/0001239545DATA · SEC EDGAR · FORM 4 · CONSOLIDATED TAPE
FREE · DAILY · 6 AM ET

The morning brief, before the bell.

One short email. Insider buys, congressional trades, and plain-English analysis.

Feedback